OUR VISION
To advance transplantation science and technology.
To provide a seamless centralized service model.
To maximize the potential for every organ to count towards saving patient lives.
Lung Bioengineering’s patient-centric approach is ingrained in our DNA.
Just like our parent companies, we are dedicated to addressing the unmet needs of our patients and delivering value to the wider communities in which we are based.
Lung Bioengineering’s patient-centric approach is ingrained in our DNA.
Just like our parent companies, we are dedicated to addressing the unmet needs of our patients and delivering value to the wider communities in which we are based.
UNITED THERAPEUTICS CORPORATION
United Therapeutics Corporation was founded in 1996 by Martine Rothblatt after her daughter was diagnosed with pulmonary arterial hypertension (PAH).
A biotech company born out of exceptional circumstances, United Therapeutics develops unique products for chronic and life-threatening cardiovascular diseases as well as cancer.
UNITHER.COM
LUNG BIOTECHNOLOGY PBC
Lung Biotechnology was established in 2006 (originally called LungRx) as part of United Therapeutics' work to address the severe shortage of transplantable organs in the U.S.
The company focuses on technologies that either delay the need for transplants or expand the supply of donor organs.
Lung Biotechnology is the first public benefit corporation subsidiary of a public biotechnology or pharmaceutical company.
LUNGBIOTECHNOLOGY.COM
LUNG BIOENGINEERING INC
Founded in 2014, Lung Bioengineering Inc. is a wholly-owned subsidiary of Lung Biotechnology PBC.
Our mission is to be the most trusted provider of centralized organ services. We deliver a seamless customer experience and support innovative research to expand the supply of transplantable organs.
As of September 2020, 150 lungs that went through EVLP at Lung Bioengineering have been transplanted as part of our clinical trials.* This number reflects our potential impact in the transplant field.
*Not related to the XPS device
OUR VALUES
OUR TEAM
EXTENSIVE EXPERIENCE
EVLP Specialist candidates must have significant clinical experience in donation/transplantation.
All EVLP Specialists undergo intensive EVLP training, both in-house at Lung Bioengineering and at Toronto General Hospital where the technology was pioneered.
100+
OUR CLINICAL TEAM HAS 100+ YEARS OF COMBINED EXPERIENCE IN DONATION, TRANSPLANTATION AND EVLP
QUALITY & COMPLIANCE ASSURANCE
Each facility has staff assigned to quality assurance and to audio-visual information technology (AV/IT).
AV/IT staff monitor the communications equipment before and during the procedure.
Their goal is to make sure transplant centers can see all the data and videos they need.
Quality Assurance staff members make sure that the correct procedures are being followed.
They also verify the clinical data as independent reviewers.
24/7/365 AVAILABILITY
Lung Bioengineering clinical staff are available at all times to triage referrals from transplant centers and carry out EVLP procedures.
Our on-call team is no more than one hour away from their respective facility at any given time.
24/7
OUR CENTERS
Each of Lung Bioengineering’s surgical suites contains specialized equipment that gives the evaluating transplant centers a clear and detailed view of every aspect of the EVLP procedure.
Find out how our services aim to increase the number of donor lungs available for transplant.